Manufacturing

A Consistent Standard for Dust Safety
The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than introducing an entirely new philosophy, NFPA 660 ... read more
From Shore to Shore
More than six decades after Hovione’s humble basement beginnings, the company is still betting on the value of being global. But today, that means something different. It’s not simply about having manufacturing sites around the world. It’s about ... read more
Can OSD Handle the GLP-1 Appetite?
The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s. read more
Root Cause Analysis of Tablet Manufacturing Issues
Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties. read more
Creating Amorphous Solid Dispersions via Spray Drying
Spray-dried ASDs are increasingly used to improve bioavailability for complex new molecules, making efficient process development tools and methodologies essential for accelerating commercialization. read more
When AI Isn't Enough
While AI offers significant advantages in data processing and analytical capability, its use in regulated industries must be carefully governed. Organizations must balance innovation with compliance by ensuring robust data integrity practices, ... read more
Accelerating Value with Data
Big data and advanced technology have reshaped most industries, and oral solid dose is no exception. read more
Driving the Data-Rich Future of OSDs
Data-rich, data-led, data-driven — these terms increasingly define modern oral solid dose development. In this roundtable, industry leaders discuss what it will take to navigate this next phase of OSD innovation. read more
Handling Machinability Challenges with Hard Shell Capsules
Machinability issues linked to capsule-related factors can disrupt production, increase waste and jeopardize delivery timelines. read more
Liquid-Filled Capsules: From Niche to Mainstream
Liquid-filled capsules are no longer a specialized workaround but a technically sophisticated platform that demands deliberate alignment among formulation design, manufacturing capability and quality strategies. read more
Digital, Continuous and Data-Rich
Advances in technologies, data, and development strategies are reshaping how oral solid dosage drugs are designed and manufactured, with a clear emphasis on lowering cost, shortening timelines, and improving quality and reliability across the life ... read more
Making 2026 Pop
Much like the winemakers who learned to harness pressure rather than fear it, OSD manufacturers are leveraging advances in manufacturing processes, formulation science, excipients and packaging technologies. read more

Novartis to Close German Tablets and Capsules Site
The drugmaker will cut 220 jobs as part of the planned closure of a production site by the end of 2028. read more
Novartis Finalizes U.S. Expansion Plan With Seventh New Facility
The facility will focus on manufacturing APIs for solid dosage tablets and capsules as part of a plan to produce all key medicines within the country. read more
Novartis Pledges $480M China Expansion
The drugmaker will build up its tablets/capsules and packaging plant in Changping, as well as expand its headquarters in Shanghai. read more
Lilly to Build $6B API Plant in Alabama for Oral Obesity Drug
The facility is one of nine U.S. manufacturing sites that Lilly has announced since 2020. read more
Novartis to Lay Off 550, End Tablets and Capsules Production at Swiss Site
The cuts will be made by the end of 2027 at Novartis' plant in Stein, as the company updates its production capabilities. read more